Viewing Study NCT05366257


Ignite Creation Date: 2025-12-24 @ 6:38 PM
Ignite Modification Date: 2025-12-31 @ 12:35 AM
Study NCT ID: NCT05366257
Status: COMPLETED
Last Update Posted: 2022-07-05
First Post: 2022-05-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Real-world Resource Use and Costs of CAR-T Therapies in Diffuse Large B-cell Lymphoma (DLBCL)
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module